Poly Medicure

50
Hold
  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE205C01021
  • NSEID: POLYMED
  • BSEID: 531768
INR
1,727.00
27.75 (1.63%)
BSENSE

Sep 23, 04:01 PM

BSE+NSE Vol: 71.83 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
1,875.00
1,669.00
1,375.00
1,115.00
923.00
786.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,875.00
1,669.00
1,375.00
1,115.00
923.00
786.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-23.00
10.00
-23.00
-14.00
-1.00
Raw Materials Consumed
604.00
579.00
471.00
429.00
363.00
263.00
Power & Fuel Cost
59.00
53.00
44.00
38.00
29.00
25.00
Employee Cost
402.00
301.00
245.00
202.00
163.00
141.00
Operating Expenses
163.00
154.00
124.00
105.00
87.00
75.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
63.00
43.00
27.00
20.00
15.00
13.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
25.00
22.00
21.00
16.00
11.00
8.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,429.00
1,214.00
1,015.00
847.00
708.00
569.00
Operating Profit (PBDIT) excl Other Income
445.00
455.00
360.00
267.00
215.00
216.00
Other Income
120.00
89.00
58.00
36.00
37.00
18.00
Operating Profit (PBDIT)
565.00
544.00
418.00
303.00
252.00
234.00
Interest
21.00
14.00
13.00
10.00
6.00
10.00
Profit before Depriciation and Tax
544.00
530.00
405.00
292.00
246.00
224.00
Depreciation
115.00
83.00
63.00
57.00
53.00
47.00
Profit Before Taxation & Exceptional Items
428.00
447.00
341.00
235.00
192.00
176.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
427.00
452.00
344.00
237.00
195.00
180.00
Provision for Tax
106.00
113.00
86.00
58.00
48.00
44.00
Profit After Tax
315.00
333.00
255.00
177.00
144.00
132.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,013.00
730.00
527.00
399.00
304.00
194.00
Profit Available for appropriations
1,335.00
1,069.00
786.00
578.00
450.00
330.00
Appropriations
1,335.00
1,069.00
786.00
578.00
450.00
330.00
Equity Dividend (%)
70.00%
70.00%
60.00%
60.00%
50.00%
50.00%
Earnings Per Share
31.79
34.13
26.92
18.69
15.28
15.25
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.30% vs 21.37% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -2.25% vs 26.59% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 49.54% vs 5.61% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -5.50% vs 30.36% in Mar 2025

Compare Profit and Loss Results of Poly Medicure
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,875.00
2,762.00
-887.00
-32.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,875.00
2,762.00
-887.00
-32.11%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0.00
-7.00
0%
Raw Materials Consumed
604.00
534.00
70.00
13.11%
Power & Fuel Cost
59.00
0.00
59.00
0%
Employee Cost
402.00
503.00
-101.00
-20.08%
Operating Expenses
163.00
483.00
-320.00
-66.25%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
63.00
91.00
-28.00
-30.77%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
25.00
55.00
-30.00
-54.55%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,429.00
1,980.00
-551.00
-27.83%
Operating Profit (PBDIT) excl Other Income
445.00
782.00
-337.00
-43.09%
Other Income
120.00
101.00
19.00
18.81%
Operating Profit (PBDIT)
565.00
883.00
-318.00
-36.01%
Interest
21.00
22.00
-1.00
-4.55%
Profit before Depriciation and Tax
544.00
860.00
-316.00
-36.74%
Depreciation
115.00
161.00
-46.00
-28.57%
Profit Before Taxation & Exceptional Items
428.00
699.00
-271.00
-38.77%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
427.00
669.00
-242.00
-36.17%
Provision for Tax
106.00
159.00
-53.00
-33.33%
Profit After Tax
315.00
509.00
-194.00
-38.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,013.00
1,859.00
-846.00
-45.51%
Profit Available for appropriations
1,335.00
2,364.00
-1,029.00
-43.53%
Appropriations
1,335.00
2,364.00
-1,029.00
-43.53%
Equity Dividend (%)
70%
205%
-135.00
Earnings Per Share
31.79
30.24
1.55
5.13%
Profit And Loss - Net Sales
Net Sales 1,875.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.30% vs 21.37% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 445.45 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -2.25% vs 26.59% in Mar 2025

Profit And Loss - Interest
Interest 21.42 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.54% vs 5.61% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 315.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -5.50% vs 30.36% in Mar 2025